Table 1

Predictors of 30-day mortality in 50 cirrhotic patients at SARS-CoV-2 diagnosis

Baseline variablesCategoryUnivariate analysis*Multivariate analysis
OR (95% CI)P valueOR (95% CI)P value
Creatinine, mg/dLContinuous2.80 (1.10 to 7.13)0.031
CPT scoreA vs B/C0.20 (0.04 to 0.83)0.027
MELDContinuous1.15 (1.03 to 1.29)0.009
CLIF-OFContinuous1.74 (1.24 to 2.44)0.0012.12 (1.23 to 3.65)0.006
Lung failure†Moderate/severe vs absent/mild1.82 (1.08 to 3.06)0.022
CCIContinuous2.91 (1.55 to 5.53)0.0014.93 (1.46 to 16.60)0.010
  • Logistic regression analysis was used to identify factors associated with 30-day mortality and used a significance level of 0.05.

  • *Variables included in univariate analysis but not significantly associated to 30-day mortality: age, sex, bilirubin, albumin, aetiology of liver disease, diabetes mellitus, comorbidities, smoking history, hepatocellular carcinoma history.

  • †Moderate/severe lung failure PaO2/FiO2 ≤200 mm Hg.

  • CCI, Charlson Comorbidity Index; CLIF, European Foundation for the Study of Chronic Liver Failure Consortium; CPT, Child-Pugh-Turcotte; MELD, Model for End-Stage Liver Disease; OF, organ failure.